Acute stroke thrombolysis: time to dispense with the clock and move to tissue-based decision making?

References

• Senes S. How we manage stroke in Australia. AIHW cat no CVD 31. Australian Institute of Health and Welfare, Canberra, Australia (2006).
   Google Scholar
• Rothwell PM. The high cost of not funding stroke research: a comparison with heart disease and cancer. Lancet357(9268), 1612–1616 (2001).
   PubMed Web of Science ®Google Scholar
• Sharma VK, Luen Teoh H, Wong LYH et al. Recanalization therapies in acute ischemic stroke:pharmacological agents, devices, and combinations. Stroke Res. Treat.2010, 672064 (2010).
   PubMedGoogle Scholar
• Seenan P, Long M, Langhorne P. Stroke units in their natural habitat: systematic review of observational studies. Stroke38(6), 1886–1892 (2007).
   PubMed Web of Science ®Google Scholar
• Annemans L, Wittrup-Jensen K, Bueno H. A review of international pharmacoeconomic models assessing the use of aspirin in primary prevention. J. Med. Econ.13(3), 418–427 (2010).
   PubMedGoogle Scholar
• Hankey GJ, Eikelboom JW. Antithrombotic drugs for patients with ischaemic stroke and transient ischaemic attack to prevent recurrent major vascular events. Lancet Neurol.9(3), 273–284 (2010).
   PubMed Web of Science ®Google Scholar
• Lees KR, Bluhmki E, von Kummer R et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet375(9727), 1695–1703 (2010).
   PubMed Web of Science ®Google Scholar
• Pillai A, Menon SK, Kumar S et al. Decompressive hemicraniectomy in malignant middle cerebral artery infarction: an analysis of long-term outcome and factors in patient selection. J. Neurosurg.106(1), 59–65 (2007).
   PubMed Web of Science ®Google Scholar
• No authors listed. Tissue plasminogen activator for acute ischemic stroke. The national institute of neurological disorders and stroke rt-PA stroke study group. N. Engl. J. Med.333(24), 1581–1587 (1995).
   PubMed Web of Science ®Google Scholar
• Nengl H. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA stroke study group. N. Engl. J. Med.333, 1581–1587 (1995).
   PubMedGoogle Scholar
• Furlan A, Higashida R, Wechsler L et al. Intra-arterial prourokinase for acute ischemic stroke: The PROACT II Study: a randomized controlled trial. JAMA282(21), 2003–2011 (1999).
   PubMed Web of Science ®Google Scholar
• Lees KR, Bluhmki E, von Kummer R et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet375(9727), 1695–1703 (2010).
   PubMed Web of Science ®Google Scholar
• Nakashima T, Minematsu K. Prospects of thrombolytic therapy for acute ischemic stroke Brain Nerve61(9), 1003–1012 (2009).
   PubMedGoogle Scholar
• Hacke W, Kaste M, Bluhmki E et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N. Engl. J. Med.359(13), 1317–1329 (2008).
   PubMed Web of Science ®Google Scholar
• Smith WS, Sung G, Starkman S et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI Trial. Stroke36(7), 1432–1438 (2005).
   PubMed Web of Science ®Google Scholar
• The Penumbra Pivotal Stroke Trial, Investigators. The Penumbra Pivotal Stroke Trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke40(8), 2761–2768 (2009).
   PubMed Web of Science ®Google Scholar
• Parsons MW, Miteff F, Bateman GA et al. Acute ischemic stroke: imaging-guided tenecteplase treatment in an extended time window. Neurology72(10), 915–921 (2009).
   PubMed Web of Science ®Google Scholar
• Hacke W, Furlan AJ, Al-Rawi Y et al Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2), a prospective, randomised, double-blind, placebo-controlled study. Lancet Neurol.8(2), 141–150 (2009).
   PubMed Web of Science ®Google Scholar
• Auriel E, Bornstein N. Neuroprotection in acute ischemic stroke-current status. J. Cell Mol. Med.14(9), 2200–2222 (2010).
   PubMed Web of Science ®Google Scholar
• Diener HC, Lees KR, Lyden P et al. NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II Trials. Stroke39(6), 1751–1758 (2008).
   PubMed Web of Science ®Google Scholar
• Sacco RL, DeRosa JT, Haley EC Jr et al.; Glycine Antagonist in Neuroprotection Americas Investigators. Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial. JAMA285(13), 1719–1728 (2001).
   PubMed Web of Science ®Google Scholar
• Singer OC, Humpich MC, Fiehler J et al. Risk for symptomatic intracerebral hemorrhage after thrombolysis assessed by DWI MRI. Ann. Neurol.63, 52–60 (2008).
   PubMed Web of Science ®Google Scholar
• Baron JC, Bousser MG, Rey A, Guillard A, Comar D, Castaigne P. Reversal of focal ‘misery-perfusion syndrome’ by extra-intracranial arterial bypass in hemodynamic cerebral ischemia. A case study with 15O positron emission tomography. Stroke12(4), 454–459 (1981).
   PubMed Web of Science ®Google Scholar
• Astrup J, Symon L, Siesjö BK. Thresholds in cerebral ischemia: the ischemic penumbra. Stroke12(6), 723–725 (1981).
   PubMed Web of Science ®Google Scholar
• Lo EH, Dalkara T, Michael MA. Mechanisms, challenges and opportunities in stroke. Nat. Rev. Neurosci.4(5), 399–415 (2003).
   PubMed Web of Science ®Google Scholar
• Mukherjee P, Kang HC, Videen TO, McKinstry RC, Powers WJ, Derdeyn CP. Measurement of cerebral blood flow in chronic carotid occlusive disease: comparison of dynamic susceptibility contrast perfusion MR imaging with positron emission tomography. Am. J. Neuroradiol.24(5), 862–871 (2003).
   PubMed Web of Science ®Google Scholar
• Kidwell CS, Alger JR, Saver JL. Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke34, 2729–2735 (1994).
   Google Scholar
• Jorgensen H, H Nakayama, HO Raaschou, TS Olsen. Stroke in patients with diabetes. The Copenhagen stroke study. Stroke25(10), 1997–1984 (1994).
   Google Scholar
• Hossman KA. Viability thresholds and the penumbra of focal ischemia. Ann. Neurol.36, 557–565 (1994).
   PubMedGoogle Scholar
• Tan JC, Dillon WP, Liu S, Adler F, Smith WS, Wintermark M. Systematic comparison of perfusion CT and CT-angiography in acute stroke patients. Ann. Neurol.61(6), 533–543 (2007).
   PubMed Web of Science ®Google Scholar
• Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS study group. Alberta Stroke Programme Early CT score. Lancet355(9216), 1670–1674 (2000).
   PubMed Web of Science ®Google Scholar
• Demchuk AM, Coutts SB. Alberta stroke program early CT score in acute stroke triage. Neuroimaging Clin. N. Am.15(2), 409–419 (2005).
   PubMedGoogle Scholar
• Butcher KS, Lee SB, Parsons MW et al.; EPITHET Investigators. Differential prognosis of isolated cortical swelling and hypoattenuation on CT in acute stroke. Stroke38(3), 941–947 (2007).
   PubMedGoogle Scholar
• Davis SM, Donnan GA, Parsons MW et al. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET), a placebo-controlled randomised trial. Lancet Neurol.7(4), 299–309 (2008).
   PubMed Web of Science ®Google Scholar
• Quain DA, Parsons MW, Loudfoot AR et al. Improving access to acute stroke therapies: a controlled trial of organised pre-hospital and emergency care. Med. J. Aust.189(8), 429–433 (2008).
   PubMed Web of Science ®Google Scholar
• Schramm P, Schellinger PD, Fiebach JB et al. Comparison of CT and CT angiography source images with diffusion-weighted imaging in patients with acute stroke within 6 hours after onset. Stroke33, 2426–2432 (2002).
   PubMed Web of Science ®Google Scholar
• Parsons MW, Pepper EM, Chan V et al. Perfusion computed tomography: prediction of final infarct extent and stroke outcome. Ann. Neurol.58(5), 672–679 (2002).
   Google Scholar
• Miteff F, Levi CR, Bateman GA, Spratt N, McElduff P, Parsons MW. The independent predictive utility of computed tomography angiographic collateral status in acute ischaemic stroke. Brain132(8), 2231–2238 (2009).
   PubMedGoogle Scholar
• Ostergaard L, Sorensen AG, Kwong KK, Weisskoff RM, Gyldensted C, Rosen BR. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: experimental comparison and preliminary results. Magn. Reson. Med.36(5), 726–736 (1996).
   PubMedGoogle Scholar
• Wintermark M, Flanders AE, Velthuis B, et al. Perfusion-CT assessment of infarct core and penumbra: receiver operating characteristic curve analysis in 130 patients suspected of acute hemispheric stroke. Stroke37, 979–985 (2006).
   PubMed Web of Science ®Google Scholar
• Bivard A, McElduff P, Spratt N, Levi C, Parsons M. Defining the extent of irreversible brain ischemia using computed tomography perfusion. Cerebrovasc. Dis.31(3), 238–245 (2011).
   PubMed Web of Science ®Google Scholar
• Maas MB, Furie KL, Lev MH et al. National Institutes of Health Stroke Scale score is poorly predictive of proximal occlusion in acute cerebral ischemia. Stroke40(9), 2988–2993 (2009).
   PubMedGoogle Scholar
• Mark WP. Perfusion CT: is it clinically useful? Int. J. Stroke3(1), 41–50 (2008).
   PubMedGoogle Scholar
• Ebinger M, De Silva DA et al. Imaging the penumbra – strategies to detect tissue at risk after ischemic stroke. J. Clin. Neurosci.16(2), 178–187 (2009).
   PubMedGoogle Scholar
• Petersen ET, Zimine I, Ho YCL, Golay X. Non-invasive measurement of perfusion: a critical review of arterial spin labelling techniques. Br. J. Radiol.79, 688–701 (2006).
   PubMed Web of Science ®Google Scholar
• Kidwell CS, Saver JL, Mattiello J et al. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann. Neurol.47(4), 462–469 (2000).
   PubMed Web of Science ®Google Scholar
• Bristow MS, Poulin BW, Simon JE, et al. Identifying lesion growth with MR imaging in acute ischemic stroke. J. Magn. Reson. Imaging28(4) 837–846 (2008).
   PubMedGoogle Scholar
• Bykowski J, Schellinger PD, Warach S. Diffusion and perfusion MRI. In: Clinical Magnetic Resonance Imaging (3rd Edition). 1538–1570 (2000).
   Google Scholar
• Chemmanam T, Campbell BCV, Christensen S et al. Ischemic diffusion lesion reversal is uncommon and rarely alters perfusion–diffusion mismatch. Neurology75(12), 1040–1047 (2010).
   PubMedGoogle Scholar
• Schellinger PD, Bryan RN, Caplan LR et al. Mismatch based thrombolysis a meta-analysis Stroke 2010: evidence-based guideline: the role of diffusion and perfusion MRI for the diagnosis of acute ischemic stroke: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Therapeutics and technology assessment subcommittee of the American Academy of Neurology. Neurology 13, 75(2), 177–185 (2010).
   PubMed Web of Science ®Google Scholar
• Calamante F, Willats L, Gadian DG, Connelly A. Bolus delay and dispersion in perfion MRI: implications for tissue predictor models in stroke. Mag. Res. Med.55, 1180–1185 (2006).
   PubMedGoogle Scholar
• Kudo K, Sasaki M, Yamada K, et al. Differences in CT perfusion maps generated by different commercial software: quantitative analysis by using identical source data of acute stroke patients. Radiology254(1), 200–209 (2010).
   PubMed Web of Science ®Google Scholar
• Takasawa M, Jones PS, Guadagno JV et al. How reliable is perfusion MR in acute stroke? Validation and determination of the penumbra threshold against quantitative PET. Stroke39, 870–877 (2008).
   PubMed Web of Science ®Google Scholar
• Neumann-Haefelin T, Wittsack HJ, Wenserski F, et al. Diffusion- and perfusion-weighted MRI: the DWI/PWI mismatch region in acute stroke. Stroke30, 1591–1597 (1999).
   PubMed Web of Science ®Google Scholar